phytanic acid has been researched along with Cerebellar Ataxia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boltshauser, E; Boxheimer, L; Capone Mori, A; Hartmann, B; Nava, E; Nuoffer, JM; Rosewich, H; Sargsyan, Y; Thoms, S | 1 |
| Beaulieu, CL; Boycott, KM; Bulman, DE; Ferdinandusse, S; Geraghty, MT; Gottlieb, CC; Lawrence, SE; Mackenzie, A; Majewski, J; McMillan, HJ; Mooyer, PA; Schwartzentruber, J; Wanders, RJ; Worthylake, T | 1 |
2 other study(ies) available for phytanic acid and Cerebellar Ataxia
| Article | Year |
|---|---|
How to Detect Isolated PEX10-Related Cerebellar Ataxia?
Topics: Ataxia; Atrophy; Cerebellar Ataxia; Child, Preschool; Genetic Testing; Humans; Male; Peroxins; Phytanic Acid; Receptors, Cytoplasmic and Nuclear | 2022 |
Specific combination of compound heterozygous mutations in 17β-hydroxysteroid dehydrogenase type 4 (HSD17B4) defines a new subtype of D-bifunctional protein deficiency.
Topics: 17-Hydroxysteroid Dehydrogenases; Cerebellar Ataxia; Fatty Acids; Hearing Loss, Sensorineural; Heterozygote; Hydro-Lyases; Mutation; Peroxisomal Multifunctional Protein-2; Phytanic Acid; Polyneuropathies; Retinitis Pigmentosa | 2012 |